Microwave tumors ablation: principles, clinical applications and review of preliminary experiences.

Department of Radiology, University of Insubria, Varese, Italy.
International Journal of Surgery (London, England) (Impact Factor: 1.44). 01/2009; 6 Suppl 1:S65-9. DOI: 10.1016/j.ijsu.2008.12.028
Source: PubMed

ABSTRACT Local ablative techniques have been developed to enable local control of unresectable tumors. Ablation has been performed with several modalities including ethanol ablation, laser ablation, cryoablation, and radiofrequency ablation. Microwave technology is a new thermal ablation technique for different types of tumors, providing all the benefits of radiofrequency and substantial advantages. Microwave ablation has been applied to liver, lung, kidney and more rarely to bone, pancreas and adrenal glands. Preliminary works show that microwave ablation may be a viable alternative to other ablation techniques in selected patients. However further studies are necessary to confirm short- and long-term effectiveness of the methods and to compare it with other ablative techniques, especially RF.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Transdermal drug delivery is hindered by the barrier property of stratum corneum. It limits the route to transport of drugs with a log octanol-water partition coefficient of 1 to 3, molecular weight of less than 500 Da and melting point of less than 200°C. Active methods such as iontophoresis, electroporation, sonophoresis, magnetophoresis and laser techniques have been investigated for the past decades on their ability, mechanisms and limitations in modifying the skin microenvironment to promote drug diffusion and partition. Microwave, an electromagnetic wave characterized by frequencies range between 300 MHz and 300 GHz, has recently been reported as the potential skin permeation enhancer. Microwave has received a widespread application in food, engineering and medical sectors. Its potential use to facilitate transdermal drug transport is still in its infancy stage of evaluation. This review provides an overview and update on active methods utilizing electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug administration with insights to mechanisms and future perspectives of the latest microwave technique described.
    Journal of Controlled Release 05/2014; · 7.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We compared imaging and pathological changes between argon-helium cryosurgical (AH) and microwave (MW) ablation in a porcine liver model. Immediately after ablation, computed tomography (CT) imaging showed that the area affected by MW ablation was considerably greater than that affected by AH ablation; moreover, the surface area of necrotic tissue was considerably greater in the AH group, whereas the depth of the necrotic area was similar. Seven days after ablation, the affected area had not changed much in the AH group, but it had significantly increased in the MW group; similarly, the surface and depth of the necrotic areas had not changed much in the AH group, but they had increased significantly in the MW group. The pathological findings showed similar definitive areas for both groups at both time points. The findings indicated that long time after both therapies, complete tissue necrosis can be achieved, but the extent and depth of necrosis differ: necrosis foci after AH ablation could be predicted by ice ball under CT image, and necrosis foci after MW ablation will increase obviously. MW ablation might therefore be suitable for tumors with a larger volume and simple anatomical structures, and AH ablation might be suitable for tumors with complex anatomical structures or those located near important organs. These two methods could therefore be used in combination in clinical settings, but details of the procedure need to be studied.
    Cryobiology 01/2014; · 1.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and AimTo evaluate the clinical benefits of transarterial chemoembolization (TACE) monotherapy or TACE combined with percutaneous microwave coagulation therapy (PMCT) and the long‐term survival rate of patients with large primary hepatocellular carcinoma (HCC) treated with these techniques. Methods This is a retrospective study involving 136 patients with unresectable large HCC (189 tumor nodules, ≥ 5.0 cm in diameter) admitted to Sun Yat‐Sen University Memorial Hospital (Guangzhou, China) between January 2004 and December 2011. The median follow‐up time was 41 months (range, 6–96 months). Of these patients, 80 patients received TACE monotherapy and 56 patients received TACE combined with PMCT. The median interval between treatments and overall survival (OS) were hierarchically analyzed using log–rank tests. ResultsAll patients successfully underwent TACE alone or TACE with PMCT with no serious complications. The median survival time was 13 months (range, 3–84 months) for the TACE group and 25 months (range, 7–96 months) for the TACE‐PMCT group. The 1‐year, 3‐year, and 5‐year OS rates were 62.5%, 17.5%, and 5.0% in the TACE group, respectively. In contrast, in the TACE‐PMCT group, the 1‐year, 3‐year, and 5‐year OS rates were 87.5%, 50.0%, and 10.0%, respectively. This difference was statistically significant between the groups (P ConclusionsTACE combined with PMCT had advantages in prolonging OS with satisfying time to progression and improving liver function in patients with large unresectable HCC. The results suggest that further prospective studies are required to confirm the findings of this study.
    Journal of Gastroenterology and Hepatology 03/2013; 28(3). · 3.63 Impact Factor